290 related articles for article (PubMed ID: 21425119)
1. Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate.
Tian S; Gan Y; Li J; Wang L; Shen J; Liu T; Ye T; Liu H; Liu D; Deng Y; Wang W
J Nephrol; 2011; 24(4):499-506. PubMed ID: 21425119
[TBL] [Abstract][Full Text] [Related]
2. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247
[TBL] [Abstract][Full Text] [Related]
3. Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis.
Tian S; Tang J; Liu H; Wang L; Shen J; Li J; Gan Y
Exp Diabetes Res; 2012; 2012():209567. PubMed ID: 22988451
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
Yuan J; Jia R; Bao Y
J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
[TBL] [Abstract][Full Text] [Related]
7. Peroxynitrite plays a key role in glomerular lesions in diabetic rats.
Xiao H; Li Y; Qi J; Wang H; Liu K
J Nephrol; 2009; 22(6):800-8. PubMed ID: 19967660
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
Gao L; Yu DM
Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
[TBL] [Abstract][Full Text] [Related]
9. [Expression of VEGF in kidney of diabetic rats].
Chen ZJ; Yang YB; Huang SM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):633-6. PubMed ID: 17718428
[TBL] [Abstract][Full Text] [Related]
10. Down regulation of aortic nitric oxide and antioxidant systems in chronic alcohol-induced hypertension in rats.
Husain K; Vazquez-Ortiz M; Lalla J
Hum Exp Toxicol; 2007 May; 26(5):427-34. PubMed ID: 17623767
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of adiponectin on uncoupling of glomerular VEGF-NO axis in early streptozotocin-induced type 2 diabetic rats.
Hou N; Huang N; Han F; Zhao J; Liu X; Sun X
Int Urol Nephrol; 2014 Oct; 46(10):2045-51. PubMed ID: 25118612
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of propyl gallate against myocardial oxidative stress-induced injury in rat.
Karthikeyan K; Sarala Bai BR; Gauthaman K; Niranjali Devaraj S
J Pharm Pharmacol; 2005 Jan; 57(1):67-73. PubMed ID: 15638995
[TBL] [Abstract][Full Text] [Related]
13. Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS.
Ding H; Hashem M; Triggle C
Eur J Pharmacol; 2007 Apr; 561(1-3):121-8. PubMed ID: 17292348
[TBL] [Abstract][Full Text] [Related]
14. Diltiazem attenuates oxidative stress in diabetic rats.
Anjaneyulu M; Chopra K
Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of hydrogen-rich saline against erectile dysfunction in a streptozotocin induced diabetic rat model.
Fan M; Xu X; He X; Chen L; Qian L; Liu J; Qing J; Chao Z; Sun X
J Urol; 2013 Jul; 190(1):350-6. PubMed ID: 23220246
[TBL] [Abstract][Full Text] [Related]
16. Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats.
Bojunga J; Dresar-Mayert B; Usadel KH; Kusterer K; Zeuzem S
Biochem Biophys Res Commun; 2004 Apr; 316(3):771-80. PubMed ID: 15033467
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.
Sugimoto H; Shikata K; Matsuda M; Kushiro M; Hayashi Y; Hiragushi K; Wada J; Makino H
Diabetologia; 1998 Dec; 41(12):1426-34. PubMed ID: 9867209
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant treatment with quercetin ameliorates erectile dysfunction in streptozotocin-induced diabetic rats.
Zhang W; Wang Y; Yang Z; Qiu J; Ma J; Zhao Z; Bao T
J Biosci Bioeng; 2011 Sep; 112(3):215-8. PubMed ID: 21664865
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
20. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
Wang S; Li Y; Huang YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
